The share
Stock Exchange listing
XVIVO Perfusion is listed on Nasdaq Stockholm mid cap list. The share has been listed on Nasdaq Stockholm mid cap since November 28, 2016. The XVIVO Perfusion share was before that listed on Nasdaq First North since October 8, 2012.
ISIN-code: SE0004840718
Ticker: XVIVO
Trading lot: 1 share
Shareholders
According to Euroclear Sweden’s official share register as of March 31, 2018, the total number of shareholders were 5 163. The top 10 largest shareholders held approximately 50.7 percent of the shares.
| Shareholder | Shares | % |
|---|---|---|
| Bure, AB Equity | 4 591 483 | 17.5% |
| Swedbank ROBUR ny teknik BTI | 1 630 000 | 6.2% |
| Eccenovo AB | 1 490 653 | 5.7% |
| SEB S.A. Client Assets UCITS. | 1 112 768 | 4.2% |
| Thomas Olausson | 1 100 000 | 4.2% |
| Fjärde AP-fonden | 1 100 000 | 4.2% |
| Handelsbanken Liv | 651 635 | 2.5% |
| Catella Småbolagsfond | 593 486 | 2.3% |
| Tredje AP-fonden | 541 408 | 2.1% |
| Försäkringsaktiebolaget, Avanza pension | 456 408 | 1.7% |
| Top 10 largest shareholders, total | 13 268 248 | 50.7% |
| Other shareholders | 12 922 248 | 49.3% |
| Total | 26 190 496 | 100% |
2012 – Allotment of acquisition cost XVIVO Perfusion decided by the Swedish Tax Agency.
In connection with Vitrolife’s distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to Xvivo Perfusion AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets allmanna rad (SKV A 2012-28)
Skatteverkets meddelande (SKV M 2012-25)
2016 – The Swedish Tax Agency decided how to tax the Vivoline shares purchased by XVIVO Perfusion.
In connection with XVIVO Perfusion´s acquisition of Vivoline Medical AB the Swedish Tax Agency decided the tax treatment for the Vivoline shares purchased by XVIVO Perfusion AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets Brevsvar ang. XVIVOs köp av Aktier och Optioner i Vivoline
